Trade margin impasse in India headed for truce?
This article was originally published in Scrip
Executive Summary
The pharma industry and its trading partners in India appear to be working towards a truce of sorts over the trade margins row, with both sides agreeing to explore certain means to recoup any net losses borne by the trade following the implementation of India's new drug pricing policy.